SCHEMBL17486108

SCHEMBL17486108

CC1(C)OC(C)(C)c2cc(-c3ncc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)cc3F)ccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 6/20 0.41
ALOX5AP P20292 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.36
HPGDS O60760 1/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 2/20 0.35
DPP4 P27487 1/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
PDGFRB P09619 1/20 0.33
KDR P35968 1/20 0.33
FLT3 P36888 1/20 0.33
ABCC1 P33527 1/20 0.32
ABCG2 Q9UNQ0 1/20 0.32
NTSR1 P30989 1/20 0.32
NFKB1 P19838 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17486161 0.84 FEN1 (0.34) FEN1ALOX5APCYP11B2
SCHEMBL17486308 0.82 FEN1 (0.36) FEN1ALOX5APL3MBTL1HPGDSMEN1
SCHEMBL17486341 0.81 MEN1 (0.39) L3MBTL1HPGDSMEN1KMT2AALDH1A1
SCHEMBL17486172 0.79 ALOX5AP (0.36) FEN1ALOX5AP
SCHEMBL17486221 0.77 ALDH1A1 (0.37) FEN1ALOX5APALDH1A1MAPTSMN1; SMN2
SCHEMBL22910049 0.74 MEN1 (0.44) L3MBTL1HPGDSMEN1KMT2AALDH1A1
SCHEMBL17486255 0.73 GRM2 (0.35) L3MBTL1CYP11B2LMNA
SCHEMBL20319819 0.72 LMNA (0.47) FEN1ALOX5APL3MBTL1MEN1KMT2A
SCHEMBL17486212 0.71 MEN1 (0.34) FEN1ALOX5APL3MBTL1MEN1KMT2A
SCHEMBL30030617 0.68 NPC1 (0.45) L3MBTL1HPGDSMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3174890-B1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2019-03-13 EP disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-9853228-B2 Metal complexes MERCK PATENT GMBH (DE) 2017-12-26 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
US-20170250353-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2017-08-31 US disclosed
WO-2016015815-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2016-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170250353-A1 METAL COMPLEXES SOD1, AP1M1, AP3M1 FEN1 1438/4885ALOX5AP 3433/4885L3MBTL1 3160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.